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Abstract Skin keratinocytes fulfil important signalling and
protective functions. Immunocytochemical experiments re-
vealed the unexpected presence of immunoreactivity for the
M-type potassium channel subunit Kv7.2 in the keratinocyte
layer of intact rat paw skin and in keratinocytes isolated
from the skin of 1-day-old rats and cultured in vitro for 3–
10 days. Application of the M-channel enhancer retigabine
(3–10 μM) to isolated cultured rat keratinocytes: (a) in-
creased outward membrane currents recorded under voltage
clamp, (b) produced ~3 mV hyperpolarization at rest, (c)
enhanced ~3-fold the release of ATP induced by the TRPV3
agonist carvacrol (1 mM) and (d) increased the amplitude of
the carvacrol-induced intracellular Ca2+ transient measured
with Fura-2. The effect of retigabine on ATP release was
prevented by the M-channel blocking agent XE991. We
conclude that rat skin keratinocytes possess M-channels
that, when activated, can modify their physiological proper-
ties, with potential significance for their sensory and other
biological functions.
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Introduction
Skin keratinocytes express several types of ion channel, which
are variably involved in the secretion of signalling molecules,
keratinocyte differentiation and the regulation of skin imper-
meability. These include voltage-gated Na+ channels [48];
epithelial ENaC (SCNN1) Na+ channels [7]; L-type (α1C)
voltage-gated Ca2+ channels [11]; a large-conductance, Ca2+-
independent K+ channel [19]; large, intermediate and small
conductance Ca2+-activated K+ channels (BKCa [19, 40],
hIK1 [22], hSK4 [21]); Kir6.1, Kir6.2 and SUR ATP-gated
inward rectifier K+ channel subunits [8]; several twin-pore K+
channels, principally TREK-1, TREK-2 and TRAAK [20] and
several transient receptor potential (TRP) cation channels [25],
including TRPV1 [18], TRPV3 [35] and TRPV4 [29], TRPA1
[1, 4] and several TRPC channels [3, 16].
In the course of a recent study on the location and function
of M-type Kv7 K+ channels in nociceptive sensory fibre
terminals in the hairy skin of the rat paw [34], we noted that
immunoreactivity for the Kv7.2 subunit was not restricted to
the nerve fibres but could also be detected in the inner layer
of the epidermis (J. Reilly, unpublished). In the present
paper, we show that this results from its expression in skin
keratinocytes and that these channels, which are normally
associated with neurons, can play a functional role in mod-
ulating the stimulated release of ATP from the keratinocytes.
Methods
Keratinocyte preparation and culture
Primary epidermal keratinocytes were cultured according to
the methods described by Dlugosz et al [15]. One-day-old
rats were killed in accordance with schedule 1 of the UK
Animals (Scientific Procedures) Act 1986. The skin from
the back and abdomen was removed and sequentially
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washed for 2 min in 0.01 M phosphate-buffered saline
(PBS; Sigma UK)/1 % antibiotic–antimycotic (100×) liquid
(Invitrogen, UK), 70 % ethanol and 0.01 M PBS (Sigma
UK)/1 % antibiotic–antimycotic (100×) liquid (Invitrogen,
UK). The subcutaneous fat was removed by gently scraping.
The skin was floated dermis side down in trypsin 0.25 %–
EDTA solution (Invitrogen, UK) overnight at 4 °C. The
following day residual dermal tissue was removed by gently
scraping. The epidermis was sliced into sections, placed into
keratinocyte serum-free media (keratinocyte SFM)
(Invitrogen, UK) supplemented with 10 % foetal bovine
serum (Invitrogen, UK) and 1 % antibiotic–antimycotic
(100×) liquid (Invitrogen, UK) and stirred for 30 min at
room temperature. The keratinocyte suspension was passed
through a nylon mesh cell strainer (70 μm; BD Falcon,
USA) and the keratinocytes harvested by centrifugation at
168×g for 5 min. The resultant cell pellet was re-suspended
in keratinocyte SFM supplemented with 1 % antibiotic–
antimycotic (100×) liquid and plated equally onto Petri
dishes or glass coverslips. The medium was replaced after
15 h with keratinocyte growth SFM and every 48 h subse-
quently. Keratinocytes were maintained for up to 3 weeks or
until confluence was reached. Older rats (up to P7) gave
much poorer yields of confluent keratinocytes.
Immunohistochemistry
Intact skin Sprague-Dawley rats (~150 g) were deeply
anaesthetised with ketamine/xylazine hydrochloride solu-
tion (1 ml/kg, i.p., Sigma, UK) in accordance with schedule
1 of the Animals (Scientific Procedures) Act 1986 and
transcardially perfused with ice-cold heparinised saline
(9 % w/v NaCl (VWR, UK), 50,000 U/l heparin (Sigma,
UK)) and then 4 % paraformaldehyde (EMS Diasum, USA)
in PBS (Sigma, UK). The skin from either the hairy dorsal
or plantar surface of the hind paw was removed, post-fixed
for 3 h with 4 % paraformaldehyde in PBS, rinsed with PBS
and then cryo-protected via immersion overnight in a 30 %
sucrose (VWR, UK)/ 0.01 % Na azide (Sigma, UK)/PBS
solution. Cryosections (40 μm) were obtained using a freez-
ing microtome (Leica Microsystems, Germany) and free
floating sections placed into PBS. Sections were incubated
with blocking solution (PBS containing 3 % goat serum and
3 % Triton® X-100 (Sigma, UK)) followed by incubation
overnight at 4 °C with primary antibody (see below). The
sections were rinsed then incubated with a fluorophore-
conjugated secondary antibody (Invitrogen, UK) for mono-
clonal antibodies, or a biotinylated secondary antibody (Sig-
ma, UK) then with Cy3-conjugated streptavidin (Sigma,
UK) for detecting polyclonal antibodies.
Cultured keratinocytes Cultured cells on cover slips were
washed twice with 0.01 M PBS and then fixed in 4 %
paraformaldehyde in PBS for 15 min. After fixation, the
cells were washed (3×) for 10 min and then incubated for
1 h at room temperature with the above blocking solution or
one containing 1 % (w/v) bovine serum albumin, plus 0.3 %
(v/v) Triton X-100™ or 0.3 % TWEEN®20 (Sigma, UK).
Cells were incubated overnight at 4 °C with the primary
antibodies then treated with secondary antibodies or biotin-
streptavidin as described above for tissue sections.
Staining of skin sections and cultured keratinocytes was
visualised using a Leica CA TCS SP2 AOBS spectral con-
focal microscope (Leica, Germany). The gain, exposure
time and wavelength were optimised for the excitation and
emission spectra of each fluorophore. Control experiments
performed without primary antibodies did not show label-
ling above background.
Antibodies The following primary antibodies, with final di-
lutions, were used: Alomone Kv7.2 rabbit polyclonal
against rat Kv7.2 (epitope residues 578–593), 0.7 μg/ml
(Alomone, Israel); Abcam Kv7.2 rabbit polyclonal against
human Kv7.2 (epitope residues 850-end of C-terminus),
3 μg/ml (Abcam, Cambridge, UK) and Neuromab mouse
Kv7.2 monoclonal against human Kv7.2 (1–50), 1:100
(Neuromab, Davis, CA, USA). The following secondary
antibodies were used: biotinylated goat anti-rabbit (Vector
Laboratories, UK), 1:333; biotinylated goat anti-mouse
(Vector Laboratories, UK) goat anti-mouse rhodamine
(Invitrogen, UK), 1:100 and goat anti-rabbit Rhodamine
Red™-X (Invitrogen, UK), 1:100. In parallel experiments,
the antibodies were tested in cultured rat sympathetic neu-
rons [17]; in these, the specificity of the antibodies for the
Kv7.2 protein was verified by adding a 10-fold excess of the
appropriate epitope (where available) 1 h before adding the
primary antibody (Supplementary Fig. S1). To assess sec-
ondary antibody specificity, in each keratinocyte experimen-
tal set a control was included in which the primary antibody
was omitted.
Electrophysiology
Macroscopic currents and membrane potentials in isolated
cultured keratinocytes were recorded using the voltage
clamp perforated-patch technique as described in [38, 43].
The bath solution was N-2-hydroxyethylpiperazine-N′-2-
ethanesulfonic acid (HEPES)-buffered Krebs’ solution
containing (in millimolar): 144 NaCl, 2.5 KCl, 0.5 MgCl2,
2 CaCl2, 10 D-glucose and 5 HEPES; pH was adjusted to 7.4
using Trizma base. The pipette solution contained (in milli-
molars): 30 KCl, 80 K-acetate, 40 HEPES, 3 MgCl2, 1
CaCl2 and 3 ethylene glycol tetraacetic acid; free [Ca
2+]i
was adjusted to 100 nM; pH was adjusted to 7.2 with KOH.
Amphotericin B 300 μg/μl was used as a perforating agent.
Pipette resistances were 5–10 MΩ when filled with the
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pipette solution. Seal resistances were >1 GΩ. Series resis-
tance was compensated 60–90 %. The mean capacitance of
the cells studied was 15.6±1.9 pF (n=9). All experiments
were performed at a controlled room temperature (22±
0.5 °C). All recordings were made using an Axopatch
200A amplifier and Digidata 1440 A/D interface (Axon
Instruments, Forster City, CA, USA) and with a pipette
holder optimized for low noise recordings (G23 Instru-
ments, UCL). All recordings were filtered with an eight-
pole Bessel filter at 5 kHz and digitized at 10 kHz. For
recording macroscopic currents in perforated-patch config-
uration, cells were held at −60 mV and commanded to
voltages from −100 to +50 mV in ramps of 25 s duration.
ATP release
ATP release from the keratinocytes was measured using a
modification of the standard luciferase reaction [30].
Keratinocytes were cultured until they reached confluence
(1–3 weeks). The keratinocyte growth SFM was replaced
with HEPES-buffered Krebs solution (composition as for
electrophysiological experiments) and incubated for 1 h at
room temperature (~21–25 °C) so that any ATP released due
to mechanical disruption or temperature change would be
metabolised. Drugs were applied for 10 min. An equivalent
volume of HEPES-buffered Krebs was added to control
dishes to control for experimental errors resulting from
possible mechanical disturbance to the keratinocytes
ATP release was determined by adding a 50-μl sample of
supernatant to an equal volume of CellTiter-Glo® Reagent
(Promega, USA). This was vortexed and equilibrated at
room temperature for 10 min. The sample was transferred
to a disposable cuvette (8×50 mm), and light emission was
measured in a luminometer (Model 20E, Promega, USA). A
standard curve was constructed using known concentrations
of ATP. The luminometer reading was linearly related to the
ATP concentration over the range 0 to 3 μM, with a slope of
1.56 U output/nM (ATP). This was used to convert
luminometer reading to concentration of ATP in 50 μl
keratinocyte supernatant. We did not convert concentrations
to amounts released since we do not know what fraction of
released ATP might or might not have been metabolized and
whether this was a constant fraction or not.
Calcium imaging
Intracellular free Ca2+ was monitored using the cell permeable
acetoxymethyl (AM) ester of Fura-2 (Fura-2 AM, Invitrogen,
UK). The keratinocytes were incubated for 1 h at room tem-
perature (22–25 ° C) with 5 μM Fura-2 AM (final concentra-
tion) dissolved in DMSOwith 10% pluronic acid (Invitrogen,
UK) and then perfused for 20 min prior to recording with
HEPES buffered Krebs containing 0.1 % (w/v) sulfinpyrazone
(to minimize loss of Fura-2; Sigma, UK). Cells were
visualised on a Nikon Diaphot 300 inverted phase contrast
microscope using an oil immersion ×40 fluorescent objective
(Nikon Instruments, USA). Cells were excited at 350 and
380 nm from a xenon short arc lamp (XBO; Osram, UK)
within a Polychrome II monochromator (TILL Photonics,
Germany), controlled by Openlab 3.1 Image acquisition soft-
ware (Improvision, UK) on an Apple Mac G4 computer.
Excitation light intensity was regulated using quartz neutral
density filters to reduce photo-bleaching of the fluorescent
probe. Emitted light was passed via a dichroic mirror
(400 nm) through a bandpass filter (520±20 nm) before being
redirected to a 12-bit greyscale Hamamatsu C4880-80 camera
(Hamamatsu, Japan). A Hamamastu CCD camera controller
enabled the control of exposure times and facilitated image
capture. Suitable pseudo-colour palettes were overlaid onto
the images to enhance visualisation. To minimise photo
bleaching, experiments were performed in a dark room, and
exposure times were kept to a minimum. Images acquired at
350 and 380 nm excitations were subjected to a ratiometric
algorithm undertaken following background light subtraction
at each excitation wavelength. For each cell, an area of cyto-
plasm was selected from which the changes in mean 350:380
ratio with time were plotted as a two-dimensional graph.
Results
Immunohistochemistry
Intact skin Intact hairy skin from the dorsal rat paw showed
strong immunoreactive staining for Kv7.2 within the epider-
mal layer (Fig. 1 a) and around the hair follicles (Fig. 1 b). In
plantar paw skin staining of Kv7.2 was apparent in the layers
adjacent to the dermal–epidermal border, in the stratum
germinativum and stratum spinosum (Fig. 2 a). Here, staining
of individual keratinocytes could be clearly seen (Fig. 2 b). No
staining was observed when the primary antibodywas omitted
(Fig. 2 c). Kv7.2 staining density in single keratinocytes was
comparable to that in neighbouring peripheral nerve fibres
(Supplementary Fig. S2).
Cultured keratinocytes Kv7.2 immunoreactivity was also
observed in isolated keratinocytes cultured from the back
skin of 1-day-old rats. Figure 3 shows immunoreactivity
detected with two different antibodies, a polyclonal anti-
body (Abcam) and a monoclonal antibody (Neutromab).
Immunoreactivity increased to a maximum after 5 days in
culture (rows b and c). No immunoreactivity was observed
in the absence of a primary antibody (row d). The transmit-
ted light images of the keratinocytes (columns 2 and 4)
showed similar morphology to those cultured to similar
densities in other studies [24].
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Membrane currents
Kv7.2 protein is a subunit of the M-channel [17, 44], a low-
threshold, non-inactivating voltage-gated K+ channel [10]. To
test for the presence of an M-current in keratinocytes, we
recorded membrane currents under perforated-patch condi-
tions from isolated cultured cells which had first been
trypsinized then replated to minimize electrical coupling (see
“Methods”). The experimental protocol we adopted is shown
in Fig. 4a. We applied voltage ramps from −100 to +50 mVat
two different speeds, fast (500 ms) and slow (25 s). With the
fast ramp, an initial inward current appeared between −40 and
−10 mV, followed by a large outward current (Fig. 4b). Using
the slow ramp, the initial inward current was replaced by an
outward current ‘hump’, followed by a more sustained out-
ward current but of much reduced amplitude. This indicates a
substantial inactivating component of the outward current, as
shown by the response to the 3-s voltage step in Fig. 4a. The
inward current and much of the outward current (including
most of the ‘hump’ current) was inhibited by 100 μM La3+
(Fig. 4b2). This suggests that (a) the inward current was
carried by a Ca2+-permeable cation channel such as a TRPV
channel [32] (see “Introduction” and below) and (b) the
‘hump’ current and much of the current activated at more
positive potentials was generated by Ca2+-activated K+ chan-
nels [21, 27, 28], with a possible contribution of Ca2+-activat-
ed Cl− channels [21] (since ECl was around −35 mV).
Since M-currents are non-inactivating, we sought evi-
dence for an M-current contribution to the outward currents
by recording the effects of the M-channel enhancer,
retigabine [42] and the M-channel blocker XE991 [44] on
the current generated by the slow (25 s) voltage ramp
(Fig. 5). Retigabine produced a small increase in mean
outward current at depolarized potentials such that the av-
erage current amplitude measured at +50 mV was signifi-
cantly greater than that of the control current or that
recorded in the presence of XE991 (Fig. 5, inset). In con-
trast, mean outward currents recorded in the absence and
presence of XE991 were not significantly different.
The variability in current amplitudes between cells might
obscure otherwise consistent but small effects of the M-
channel modulators. Therefore, since we used the same
schedule of drug applications in each experiment (control–
retigabine–XE991), we carried out a within-experiment com-
parison by measuring the current ratios at +50 mV
retigabine/control, XE991/control and XE991/retigabine and
Fig. 1 Kv7.2 antibody staining within keratinocytes in intact rat skin.
Left side images fluorescence; right side transmitted light images. a
Keratinocytes immunoreactive to Kv7.2 (Alomone) within the outer
epidermal layer. b Keratinocytes immunoreactive to Kv7.2 (Abcam)
within the epidermal layer surrounding the hair follicle. The arrows in
the transmitted light images point to hair follicles. Scale bar 40 μm
Fig. 2 Immunoreactivity for Kv7.2 within the epidermis of plantar
skin. a, b Kv7.2(Alomone) immunoreactivity within rat plantar skin
with corresponding transmitted light images on the right. c Secondary
only antibody. Scale=40 μm
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assessing whether their means differed significantly from a
null-hypothesis ratio of 1.0 (Table 1). The ratios
retigabine/control and XE991/retigabine were significantly
different from unity at P<0.025 and P<0.0025, respectively;
that for the ratio XE991/control was marginally outside the
5 % significance level at P=0.052. Thus, it would seem likely
that functional M-channels (presumably containing Kv7.2
subunits) are present in these keratinocyte membranes, con-
tributing perhaps a quarter of the outward current at positive
potentials, and that this current is enhanced ~20 % in the
presence of retigabine.
Membrane potential
Several attempts were made to record the effects of M-
channel modulators on the resting membrane potential of
the cultured keratinocytes. In most (5+) cells successfully
patched, the apparent resting potential was regarded as too
positive (≤−25 mV) and/or too unstable, and recordings
aborted or rejected. However, one cell showed a good and
relatively stable resting potential (~−75 mV; Fig. 6). In this
cell, retigabine (10 μM) produced a clear hyperpolarization
of ~3 mV, which was partly reversed on adding 3 mM
XE991 and fully recovered on washing. This accords with
the effect of retigabine on nerve cells, in which it produces a
resting hyperpolarization by shifting the M-channel activa-
tion curve so that channels now open at negative potentials
where they would normally be closed [42].
ATP release
To assess the maximum ATP-releasing capacity of cultured
keratinocytes, we applied 50 μl NaOH to a series of
keratinocyte cultures for 10 min to give a final bath concen-
tration of 4 % [30]. This increased the ATP concentration in
the surrounding medium by about 10-fold over that recorded
on simply adding an aliquot of Krebs’ solution, from a mean
of 34.6±5.2 nM (n=5) to 420±49.5 nM (n=6) (Fig. 7a).
To provide a more physiological stimulus for ATP re-
lease, we used the TRPV3 agonist carvacrol [46]. TRPV3 is
Fig. 3 Immunoreactivity to
Kv7.2 channel in rat
keratinocytes observed with
two different antibodies and
after differing times in culture.
Fluorescent images to the left,
transmitted light images to the
right. a Day 3 in culture; b
day 5; c day 10; d day 3 with
secondary antibody only. Scale
bar=20 μM
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Fig. 4 Membrane currents recorded from an isolated cultured rat
keratinocyte. a Voltage and current protocol (upper trace current, lower
trace voltage). The cell was held at −60 mV, prepulsed to −100 mVand
then commanded to +50 mV with a 25-s voltage ramp. After returning
to −60 mV, two 3-s commands to −20 and +20 mV were applied.
Finally, the voltage-ramp procedure was re-applied but at a faster speed
(500 ms). Currents obtained before (black) and after (grey) adding
100 μM LaCl3 are shown. The zero current level in the upper (current)
trace is indicated by the dashed line. b Current–voltage relations for
500 ms (grey) and 25 s (black) ramps (1) before and (2) after adding
LaCl3. Currents were leak-subtracted by subtracting extrapolated linear
currents from −100 to −60 mV. Current scale pA/pF
Fig. 5 Superimposed averaged
mean currents (pA/pF) generated
by 25 s voltage ramps from −100
to +50 mV in 9 keratinocytes
exposed sequentially to Krebs’
solution (control, black), 10 μM
retigabine (amber) and 10 μM
XE991 (violet). 100 µM LaCl2
was subsequently added to 7 of
the same 9 cells (brown).
Currents were leak-subtracted by
subtracting extrapolated linear
currents from −100 to −60 mV.
Inset means±SEMs of current
amplitudes at +50 mV.C control,
R retigabine, X XE991. Means±
SEMs (pA/pF) were: control,
1.06±0.23 (n=9); retigabine,
1.35±0.33 (n=9); XE991, 0.94±
0.33 (n=9); La3+, 0.40±0.26
(n=7). For the bracketed
columns, P values (two-tailed
t test) were: * <0.05; ** <0.03
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abundantly expressed in keratinocytes [25, 31], and its acti-
vation readily induces ATP release [26]. As shown in
Fig. 7b, 1 mM carvacrol for 10 min produced a consistent
and significant (P<0.01) increase in ATP release of >2-fold
over the 10-min exposure period, from 30.4±3.5 nM (n=4)
with Krebs’ solution to 70.9±3.5 nM (n=4).
Addition of the M-channel enhancer retigabine (3 μM
final bath concentration) to the carvacrol solution led to a
further 3-fold increase in the amount of ATP released by
carvacrol, from 191±31.8 nM (n=6) to 616±116 nM (n=5)
(Fig 7c). Ten micromolars retigabine produced a similar
effect (Fig. 7d). This latter effect was annulled by prior
addition of the M-channel blocking agent XE991 (10 μM;
Fig. 7d) so presumably results from activation of M-
channels. Retigabine (10 μM) did not affect spontaneous
ATP release in the absence of carvacrol ([ATP]: controls
15.2±5.9 nM, n=4); retigabine 14.3±7.8 nM, n=3)), nor
did addition of 50 μl of the solvent (5 % DMSO) ([ATP]:
controls 15.1±8.6 nM, n=4; DMSO 12.0±3.8 nM, n=4)).
XE991 (10 μM) in the absence of retigabine had no signif-
icant effect on either the spontaneous release ([ATP]: con-
trols 73.3±43.7 nM, n=4); XE991 98.4±19 nM, n=3)) or
the enhanced release produced by carvacrol ([ATP]: carva-
crol 203.3±32.9 nM, n=4; carvacrol+XE991 359.8±
84.5 nM, n=4).
Intracellular Ca2+ changes
Carvacrol has been reported to increase intracellular [Ca2+]
in TRPV3-containing or expressing cells [46]. Since that
increase required extracellular Ca2+, it presumably resulted
from entry through the Ca2+-permeable TRPV3 channels
[45]. In accordance with this, carvacrol increased intracel-
lular [Ca2+] in cultured keratinocytes as measured from the
350:380 fluorescence ratio in Fura-2 loaded cells (Fig. 8).
Fura-2 signals across different keratinocytes were highly
variable, but signals with repeated carvacrol applications
to the same keratinocyte were reasonably consistent, albeit
with some desensitization as previously reported [46].
Hence, to test whether retigabine affected the Ca2+ signal,
we applied carvacrol twice to the same cell then measured
the ratio of the second to first responses (R2/R1) on adding
either Krebs’ solution or 10 μM retigabine 5 min before the
second response (Fig. 8a). As shown in Fig. 8b, the second
response was smaller on average on adding Krebs solution
(R2/R1=0.73±0.10, n=33) but was consistently increased
after adding 10 μM retigabine (R2/R1=1.18±0.04, n=24);
the difference between retigabine and Krebs’ solution was
highly significant (P<0.01). Retigabine itself did not pro-
duce any consistent change in resting [Ca2+].
Discussion
The main points emerging from these experiments are that
the M-channel Kv7.2 subunit protein is consistently
expressed in rat skin epidermal keratinocytes and that these
cells also possess functional (or potentially functional)
membrane M-channels. Antibodies to Kv7.2 were selected
as most helpful in seeking the presence of M-channel pro-
teins because this subunit is not only a component of the
heteromeric Kv7.2/7.3 M-channel observed in peripheral
neurons [17, 44] (and indeed is essential for their functional
expression [33]) but also because Kv7.2 subunits can form
functional M-channels in the absence of other subunits
[37–39]. Using Kv7.2 antibodies, we found a strong band
of immunoreactivity in the keratinocytes in the epidermis
and around hair follicles in intact rat skin and in
keratinocytes from early postnatal rat skin when cultured
for a few days in vitro. This is likely to be due to specific
staining of Kv7.2 protein since (a) it was replicated by three
antibodies directed at different epitopes and (b) where tested
(supplementary Fig. S1), it was prevented by the subunit-
specific epitope peptide.
Our primary evidence for functionality (or at least, po-
tential functionality) of the Kv7.2 protein as a subunit of the
M-channel rests on the effects of the selective M-channel
enhancer retigabine. This drug (a) produced a small (~20 %)
but consistent increase in outward membrane current, (b)
Table 1 Within-experiment measurements of current ratios at +50 mV
from the experiments illustrated in Fig. 6
Retigabine/
control
XE991/
control
XE991/
retigabine
Mean ratio 1.208 0.730 0.583
SEM 0.0896 0.147 0.107
N 9 9 9
P (difference from 1.0, one tail) 0.024 0.052 0.0022
Fig. 6 Retigabine can hyperpolarize a keratinocyte. Membrane poten-
tial recording from a cultured keratinocyte. Perforated-patch recording
as for Figs. 4 and 5 (see “Methods”). Retigabine (10 μM) was added
for the duration shown by the upper black bar and supplemented with
3 μM XE991 for the period shown by the lower grey bar
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hyperpolarized a keratinocyte with a high (−75 mV) resting
potential, (c) augmented the release of ATP by the TRPV3
agonist carvacrol and (d) enhanced the increase in intracel-
lular Ca2+ produced by carvacrol. The enhanced release of
ATP by retigabine was suppressed by the M-channel
blocking drug XE991, showing that this effect at least was
unambiguously due to the action of retigabine on M-
channels. On the other hand, XE991 alone did not produce
a clearly significant (P=0.052) reduction in voltage-
activated membrane current (which was dominated by
Ca+-activated outward currents) and did not significantly
affect either the stimulated or resting release of ATP. This
may suggest that, in these cultured cells at least, the density
of functional M-channels is rather low compared with that in
peripheral neurons and/or that very few of these voltage-
gated channels are activated at the membrane potential of
these cells and only carry appreciable current when their
activation is enhanced by retigabine. On the other hand, the
channels might well be present at a higher density in adult
keratinocytes than in cultured immature keratinocytes and
then might form a more substantial component of resting
membrane current, since Kv7.2 immunoreactivity was ap-
preciably stronger in adult rat skin keratinocytes than in the
cultured cells and indeed comparable to that in neighbouring
nerve fibres (Supplementary Fig. S2).
TRPV3 channels are Ca2+-permeable [45], and as
reported previously for other TRPV3-expressing cells [46],
their activation by carvacrol increased intracellular Ca2+ in
our cultured keratinocytes (Fig. 8). Since raising intracellu-
lar Ca2+ in keratinocytes can release ATP [23], as in some
Fig. 7 Stimulated ATP release from cultured keratinocytes (a, b) and
effects of retigabine thereon (c, d). Data in a–d are from four separate
keratinocyte cultures. Ordinates show concentrations of ATP ([ATP], in
nanomolars) in 50 μl aliquots of Krebs’ solution overlying the
keratinocyte cultures (total bath volume 500 μl) determined using the
luciferase assay (see “Methods”). Aliquots were taken 10 min after
adding 50 μl Krebs’ solution to the keratinocyte chambers (controls,
Con) or 10 min after adding: a NaOH (final bath concentration 4 %), b
carvacrol (Carv, final bath concentration 1 mM), c 1 mM carvacrol
alone or 1 mM carvacrol with 10 μM added retigabine (Ret) and d
1 mM carvacrol, 1 mM carvacrol with 10 μM retigabine and 1 mM
carvacrol+10 μM retigabine 2 min after pre-addition of 10 μMXE991.
Numbers in brackets are numbers of culture dishes sampled from each
culture; **P<0.01 (difference from controls or, in d, between carva-
crol+retigabine with and without added XE991)
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other cells (e.g. [6, 9, 23]), it seems reasonable to suppose
that the rise in [Ca2+]in is primarily responsible for the
release of ATP by carvacrol, though other mechanisms for
release are possible [2, 5]. Retigabine produced a significant
increase in the carvacrol-induced rise in [Ca2+]in though
whether this is quantitatively sufficient to explain the in-
creased ATP release in uncertain.
Likewise, the mechanism whereby increasing M-channel
activity with retigabine increases the carvacrol-induced Ca2+
transient and ATP release is, as yet, equally unclear. One
possibility is that an M-current-induced hyperpolarization
increases the driving force for Ca2+ entry through the
TRPV3 channels. The hyperpolarization at rest potential
was rather small (~3 mV; Fig. 6) but since the channels
are voltage-sensitive, the retigabine-enhanced channels may
have a much more significant effect in reducing the TRPV3-
induced depolarization (essentially clamping the membrane
potential near to the resting potential) and hence increasing
the Ca2+ driving force at the peak of TRPV3 activation.
Additionally, the activated M-channel might have some
more direct effect on the TRPV3 channel to enhance its
activity or sensitivity to carvacrol. Thus, Kv7.2 and TRPV1
have been reported to co-precipitate when co-expressed in
HEK 293 cells, though in this case without effect of
retigabine on the action of the TRPV1 ligand, capsaicin
[47]. Further tests for Kv7.2-TRPV3 interaction might be
worthwhile.
Physiologically, TRPV3 (and TRPV4) channels in
keratinocytes are suggested to mediate keratinocyte
thermosensation, probably through the release of ATP and
activation of subjacent sensory fibres [25]. Thus, in co-
cultures of dorsal root ganglion neurons with keratinocytes,
the response of the neurons to an applied heat ramp has been
shown to result from activation of the keratinocyte TRPV3
channels and the release of ATP onto the adjacent neurons,
rather than to a direct effect on the neurons [26]. Assuming
that retigabine has a comparable effect on the response of
keratinocyte TRPV3 channels to heat as that to carvacrol
observed in the present study, retigabine would be expected
enhance skin thermosensation. Thus, the fact that retigabine
exerted the opposite (suppressant) effect on thermally-induced
skin peripheral afferent discharges in situ [34] would seem to
rule out the possibility that the latter effects were mediated
indirectly via the keratinocytes. On the other hand, the effects
of retigabine on keratinocyte responses might imply some
limitation to the prospective utility of retigabine in suppress-
ing pathological nociceptive activity [36].
Apart from thermal sensation, keratinocyte TRPV3 chan-
nels and local ATP release may be involved in other aspects
of skin function including vasodilator responses and the
regulation of skin structure and permeability [12, 25]. For
example, openers of some other K+ channels have been
reported to accelerate epidermal barrier recovery after bar-
rier disruption [13]. Keratinocytes also possess Gq-coupled
receptors such as purinergic P2Y receptors [14] and brady-
kinin B2 receptors [41], which would be expected to mod-
ulate M-channel activity [10]. Thus, the presence of M-
channels and their effects noted in the present paper may
have rather broad implications for skin biology and possibly
some therapeutic implications for wound healing
Fig. 8 Retigabine enhances the increase in intracellular [Ca2+] in
cultured keratinocytes produced by carvacrol. a Representative Ca2+
signals, measured as increases in the 350:380-nm fluorescence signal
in Fura-2 preloaded cells and recorded from two keratinocytes follow-
ing two applications to each of 1 mM carvacrol for 3 min. The top
trace shows representative responses to two successive applications of
carvacrol. In the lower trace, the second carvacrol application was
preceded by the addition of retigabine (Ret: bath concentration
10 μM). b The mean ratio of the second-to-first responses (R2/R1)
following addition of Krebs’ solution (Carv+Krebs) or retigabine
(Carv+Ret) before the second response. Bars are SEM, number of
cells in brackets. The asterisk (**) indicated that the R2/R1 ratio is
significantly greater when R2 was preceded by retigabine than when it
was not (P<0.01)
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